Characterization of GABA receptors.
S J Enna1, Kenneth E McCarson1
1University of Kansas Medical Center, Kansas City, Kansas.
Current Protocols in Pharmacology
|February 11, 2014
Summary
This unit details ligand-binding assays for GABA receptors in brain tissue. These methods quantify drug affinity for GABAA, GABAB, and homomeric ρ GABAA receptor sites.
Area of Science:
- Neuroscience
- Pharmacology
Background:
- GABA receptors are crucial in the central nervous system (CNS).
- GABA binding sites are also found in peripheral organs, but CNS research is primary.
- Understanding these sites is key for developing CNS-targeting drugs.
Purpose of the Study:
- To describe ligand-binding assays for specific GABA receptor subtypes.
- To enable the characterization of receptor recognition sites in brain tissue.
- To provide a method for determining unlabeled compound affinity for GABA binding sites.
Main Methods:
- Development of ligand-binding assays.
- Focus on GABAA, GABAB, and homomeric ρ GABAA (formerly GABAC) receptor recognition sites.
- Utilizes brain tissue for receptor site analysis.
Main Results:
- Established assays for quantifying ligand binding to key GABA receptor subtypes.
- Demonstrated the utility of these assays for CNS receptor research.
- Provided a framework for assessing compound affinity at GABA binding sites.
Conclusions:
- The described ligand-binding assays are effective tools for studying GABA receptors in the brain.
- These methods facilitate the investigation of drug interactions with GABAA, GABAB, and ρ GABAA receptors.
- The assays are valuable for neuropharmacological research and drug discovery.
More Related Videos
07:16Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
14.1K
08:04Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
Published on: June 6, 2025
1.5K
Related Concept Videos
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
4.6K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
4.6K
01:30Transducer Mechanism: G Protein–Coupled Receptors
9.0K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
9.0K
01:15G Protein-coupled Receptors
14.1K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
14.1K
01:15G Protein-coupled Receptors
2.4K
2.4K
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
1.7K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.7K
01:22Activation and Inactivation of G Proteins
8.9K
Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high...
8.9K